Introducing the New PREVENTEST™ from GeneID Advanced Molecular Diagnostics, LLC

PrevenTest is a non-invasive cancer risk pre-disposition testanalyzing 31 genes linked to 8 of the most prevalent anddevastating solid tumor hereditary cancers:

Breast, Ovarian, Colorectal, Endometrial, Prostate,

Pancreas, Stomach and Skin

Testing additional actionable genes beyond BRCA1 &BRCA2 increases the detection of cancer-causingmutations by 43% (Cancer, 2015 pp 25-33)

Hereditary Cancer Risk predictive testing is covered by Medicare and many Medicaid and commercial plans

Genetic Consultation services are available for test resultanalysis and preventative planning

Test performed with a simple mouth rinse and buccal swab

Results returned within 7-9 business days after insuranceverification, via web portal, HIPAA compliant email, faxand hard copy